Abstract
In response to DNA damage, Escherichia coli cells activate the expression of the toxin gene tisB of the toxin–antitoxin system tisB-istR1. Of three isoforms, only the processed, highly structured +42 tisB mRNA is active. Translation requires a standby site, composed of two essential elements: a single-stranded region located 100 nucleotides upstream of the sequestered RBS, and a structure near the 5′-end of the active mRNA. Here, we propose that this 5′-structure is an RNA pseudoknot which is required for 30S and protein S1-alone binding to the mRNA. Point mutations that prevent formation of this pseudoknot inhibit formation of translation initiation complexes, impair S1 and 30S binding to the mRNA, and render the tisB mRNA non-toxic in vivo. A set of mutations created in either the left or right arm of stem 2 of the pseudoknot entailed loss of toxicity upon overexpression of the corresponding mRNA variants. Combining the matching right-left arm mutations entirely restored toxicity levels to that of the wild-type, active mRNA. Finally, since many pseudoknots have high affinity for S1, we predicted similar pseudoknots in non-homologous type I toxin–antitoxin systems that exhibit features similar to that of tisB-IstR1, suggesting a shared requirement for standby acting at great distances.
INTRODUCTION
In enterobacteria like Escherichia coli, DNA damage induces the SOS stress response genes, one of which encodes the toxin of the type I toxin–antitoxin (TA) locus tisB-istR1. During normal growth, tisB is repressed by the master regulator LexA (1–3). It encodes a pore-forming toxin that arrests growth through membrane depolarization and promotes the formation of persisters in response to stress (4–7). Persisters are non-growing, yet sometimes metabolically active cells that tolerate antibiotic treatment and counteract host immune responses (8,9). The tisB primary transcript, denoted +1 tisB mRNA (Figure 1A), is translationally inactive since the tisB ribosome binding site (RBS) is structurally sequestered (10,11). Maturation by endonucleolytic cleavage gives rise to the +42 tisB mRNA. Despite an identically sequestered RBS, this mRNA is translationally active, and hence confers toxicity to cells when overexpressed (4,10).
The apparent paradox of mRNAs with structurally inaccessible RBS’s was solved conceptually by the ‘ribosome standby’ model (12,13). We showed previously that the +42 tisB mRNA, but not the inactive +1 variant, carries a largely unstructured segment far upstream of the tisB RBS. The 30S ribosomal subunit must bind this site to subsequently move towards the RBS located ≈100 nt downstream (11,14). We learned that this standby site is composed of two distinct elements: a single-stranded region and a 5′ terminal structure (14). Both are required for standby-mediated translation of tisB mRNA. Under non-stress growth conditions, the low, uninduced levels of +42 tisB mRNA are inhibited by the constitutively transcribed antitoxin RNA IstR1. IstR1 base-pairs to the single-stranded region near the 5′-end, thus preventing standby and, thereby, TisB translation and toxicity (10,11). We recently showed that a structure near the 5′-end of +42 mRNA was a second essential element for standby. Mutations that disrupted the 5′-most stem-loop, or lacked it altogether, severely impaired ribosome binding to, and translation of, tisB mRNA. This paper also showed that ribosomal protein S1 alone binds to both standby elements, is needed to promote 30S subunit binding to this location, and facilitates the unwinding of downstream structure to reach the tisB RBS (Figure 1A) (14).
The importance of S1 for standby is intriguing. In E. coli, this protein has ubiquitous roles in translation (15–18). It is the largest ribosomal protein, and is not always stably associated with ribosomes (18,19). Through its six OB-fold domains, it binds many RNA elements (20), e.g. single-stranded AU-rich sequences near RBS’s of mRNAs to enhance translation (21–23). Conversely, since S1 also recognizes complex RNA structures, its binding and unwinding activity is sometimes required for translation of structured mRNAs (24–29). Of interest for the question addressed here, S1 avidly binds RNA pseudoknot structures, which involve hairpin apical loops base-pairing to other, often flanking, single-stranded RNA segments. The most prevalent pseudoknot, denoted H-type, displays co-axial stacking of two stem regions (Figure 1B; stems S1 and S2), connected by three loop regions (Figure 1B; L1, L2, and L3) (30–32). These RNA structure elements are often critical for regulation of gene expression in viruses, pro-, and eukaryotes (33,34). Pseudoknots are structurally diverse, differing in topology due to variations in the length of the loops and helices that they are built from (31,32,35). Early evidence of S1/RNA pseudoknot interactions was obtained by SELEX experiments which identified an H-type RNA pseudoknot bound by S1 with nanomolar affinity (Supplementary Figure S1) (36). Subsequently, S1 was shown to bind pseudoknots in tmRNA (37–39), the preQ1 riboswitch (40), and the rpsO mRNA. In the latter case, binding is essential for unwinding and docking of the mRNA onto the 30S subunit platform (26) (Supplementary Figure S1).
Our recent work revealed that a structure at the 5′-end of +42 tisB mRNA is required for S1 binding and standby activity. Given the preference of S1 for RNA pseudoknots, we speculated that such an element might explain how this ribosomal protein anchors the 30S subunit to facilitate high affinity binding to the entire standby site. Here, we present results that support this hypothesis, by demonstrating that point mutations in the apical loop of the 5′-end stem-loop reduce affinity of the mRNA for 30S subunits and purified S1. Loss of binding is associated with impaired 30S initiation complex (30S-IC) formation in vitro and alleviated toxicity in vivo. A compensatory mutation in a flanking single-stranded loop is suggested to restore the pseudoknot, hereby allowing translation of the inactive mutant mRNA. We corroborated our conclusions by analyzing three additional pairs of double-nucleotide mutations in stem 2 of the predicted pseudoknot. In vivo toxicity was abolished in all cases, but restored by the compensatory mutations. Finally, we suggest that toxin mRNAs from non-homologous, but similarly organized, TA systems also carry predicted RNA pseudoknots at equivalent locations.
MATERIALS AND METHODS
Bacterial cultures
Strains and plasmids are listed in Supplementary Table S1. Cells were grown aerobically at 37°C in L Broth (5 g/l yeast extract, 10 g/l tryptone,10 g/l NaCl) and, when required, ampicillin was added at 100 μg/ml or kanamycin at 50 μg/ml. Plasmids pBAD, pBAD+1_tisB and pBAD+42_tisB, as well as pJV974–1, were published previously (4,10). The pBAD plasmid series was used as template for site-directed mutagenesis with primer design based on NEBaseChanger (http://nebasechanger.neb.com/). After PCR amplification with phosphorylated primers, template plasmids were digested with FastDigest DpnI (ThermoFischer Scientific, FD1703) for 30 min at 37°C followed by purification of the PCR products with the GeneJET PCR Purification Kit (ThermoFisher Scientific). Plasmids were re-circularized with T4 DNA ligase (ThermoFischer Scientific, 15224017) and transformed into chemically competent Escherichia coli Top10 cells (C404003, Invitrogen). The mutated pBAD plasmids were isolated with the GeneJET Plasmid Miniprep Kit (ThermoFisher Scientific).
Toxicity assays
Overnight bacterial cultures derived from single colonies were diluted 1:100 in fresh LB medium and grown in either 100 ml flasks or black 96-well plates with clear flat bottom (Costar®) at 37°C. Optical density (600 nm) was measured at 5 min intervals in a plate reader (Tecan infinite pro). At OD600 = 0.5, either arabinose or glucose (0.2% or 0.025% final concentration) was added to induce or prevent induction of expression from the pBAD plasmids (Supplementary Figure S1). OD values were corrected for media-only background. For spotting assays, an aliquot of a 30 min induced culture with either glucose or arabinose was withdrawn, and 10-fold serially diluted in fresh LB media. 5 μl aliquots were pipetted on fresh LA-Amp plates, followed by o.n. incubation at 37°C. Images were captured using a Chemidoc (Biorad, image lab 4.0 software).
Northern blot analysis
Aliquots from bacterial cultures with either arabinose or glucose were withdrawn and mixed with 0.25 volume of 95% ethanol, 5% phenol, and frozen in liquid nitrogen. After thawing on ice, cells were pelleted by centrifugation (15 min at 4000 g) and RNA extracted by hot-phenol (41). 10 μg of total RNA was mixed with 2 × RNA loading buffer (95% (v/v) formamide, 0.025% (w/v) bromophenol blue, 0.025% (w/v) xylene cyanol), denatured for 2 min at 90°C, and separated on a 6% sequencing gel. After electrophoresis, RNAs were transferred to an Amersham HybondTM-N+ membrane (GE Healthcare) by electro-blotting, and UV-crosslinked. 5′-end-labeled oligodeoxyribonucleotide probes were used for detection of tisB mRNAs (ced267) and the 5S rRNA (5S-long). Pre-hybridization and hybridization of the membrane was carried out in Church and Gilbert hybridization buffer (Church & Gilbert, 1984) at 50°C. Signals were detected using a PhosphorImager screen and a PMI scanner™ (Biorad).
RNA preparation
DNA templates with T7 promoter sequences were generated by PCR with hot start Phusion (primers in Supplementary Table S2). Transcription of RNAs was done with the Megascript kit (Life technologies, #AM1330) according to the manufacturer's instructions. The encoded hammerhead ribozyme (HH-ribozyme) sequence was completely removed with 10 cycles of 3 min at 60°C followed by 3 min at 25°C in a PCR block, after Turbo DNase treatment. The general template design for specific cleavage using the HH-ribozyme is shown in Supplementary Figure S2. RNAs were purified from 6% sequencing gels, and RNA bands detected by UV-shadowing. RNA was passively eluted in elution buffer (300 mM Na-acetate, 0.1% SDS, 1 mM EDTA) o.n. at 4°C, followed by phenol extraction, ethanol precipitation, and drying. Dried RNA pellets were dissolved in RNAse-free water, concentration obtained by Nanodrop, and quality evaluated by SybrGold staining after denaturing PAGE.
Fluorescein (FAM) labeling of mRNAs
The strategy used for FAM-labeling of RNA is described in (14). Briefly, 5′OH +106 RNA generated by hammerhead ribozyme cleavage (see above), was splint-ligated to FAM-RNA adaptors to reconstitute the 5′FAM +42 tisB mRNA (idtDNA) following the strategy described in (42,43) with modifications listed hereafter. 300 pmol of 5′OH +106 RNA was incubated with 25 U of T4 PNK (Thermo Scientific™, EK0031) and 0.5 mM ATP for 1 h at 37°C to mono-phosphorylate the 5′-end of the mRNA. ATP and ADP were removed on Illustra MicroSpin G50 columns (GE Healthcare, 27-5330-01), followed by phenol extraction and precipitation. Next, 300 pmol of phosphorylated RNA, 450 pmol of splint-DNA oligo, and 600 pmol of FAM-adaptor were mixed in a 25 μl volume. For RNA/DNA heteroduplex formation, the reaction mix was denatured for 2 min at 95°C, followed by slow cooling to r.t. The reaction mix was supplemented (total volume 50 μl) with 1x T4 RNA ligase buffer (Thermo Scientific™, EK0013), water, 10 U of SUPERase•In™ RNase Inhibitor (Invitrogen™, AM2696), 8% PEG4000, and 360 Weiss Units of T4 DNA ligase (Thermo Scientific™, EK0013). Ligation was carried out o/n at 30°C, followed by phenol extraction and precipitation. FAM-ligated RNAs were purified on 6% sequencing gels. As a control, incorporation of fluorescein was confirmed using a Chemidoc (Biorad, image lab 4.0 software, fluorescein settings). Bands corresponding to the desired RNA sizes were cut out, and RNA eluted o.n. at 4°C as described above.
Ribosome and S1 purification
30S ribosomes and ribosomal protein S1 were purified as in (14).
Toeprint assays
Toeprint assays were done according to (14). All steps were at 37°C unless otherwise specified. Before use, each mRNA together with dNTPs (0.5 mM final concentration) and radiolabeled ced70 primer (150 000 cpm) were denatured for 1 min at 90°C, followed by 1 min on ice. RNAs were refolded for 10 min in toeprint reaction buffer (10 mM Tris–HCl pH 7.6, 100 mM K-acetate, 10 mM Mg-acetate, 1 mM DTT). Pre-activated 30S (100 nM final concentration; 15 min at 37°C in 1× RT-buffer) were added for 10 min, followed by addition of tRNAfMet (300 nM). 30S-IC formation was allowed for 20 min. Primer extension was carried out by addition of 50 U of SSIV RT (Invitrogen). After phenol/ chloroform/ isoamyl alcohol extraction (25/24/1), template RNAs were hydrolyzed by KOH treatment (300 mM) for 3 min at 90°C, followed by 1 h at 37°C. KOH was neutralized with acetic acid (600 mM), and the cDNA precipitated with Na-acetate and ethanol. After centrifugation and washes with 70% ethanol, cDNA was dissolved in 1 vol of water and 1 vol of 2× RNA loading dye (R0641, Thermo Fisher) and separated on an 8% sequencing gel. Signals were detected using a PhosphorImager screen and a PMI scanner™ (Biorad).
30S and S1 binding assays
30S subunit and S1 binding to the +42 tisB mRNA was assessed by measuring fluorescent anisotropy change with a 5′end FAM-labeled +42 mRNA. 10 nM of labeled mRNA was denatured and refolded as described above at 37°C for 15 min. 30S subunits or purified S1 (pre-incubated in toeprint reaction buffer at 37°C) were added to the reaction mix with or without competitor RNA (50-fold molar excess of unlabeled mRNA only for 30S binding assays, 50-fold and 10-fold molar excess of unlabeled mRNA, respectively, for S1 binding assays). Complex formation was allowed for 20 min at 37°C (final assay volume 50 μl). Three 15 μl aliquots were loaded on 384-well plates. Fluorescein was excited with polarized light at 485 nm and polarized parallel and orthogonal emission at 535 nm was recorded using a Tecan SPARK 10M. Anisotropy was calculated with the following equation:
where (∥) is parallel and (⊥) is orthogonal polarized emission, respectively. All experiments were done in triplicate.
SHAPE structural probing
Reactions were done in a final volume of 15 μl. 2 pmol of RNA was denatured for 1 min at 90°C followed by 2 min incubation on ice. RNA was refolded for 5 min at 37°C in MKM buffer (HEPES 50 mM pH 8, Mg-acetate 5 mM, K-acetate 100 mM). Probing was carried out for 70 s at 37°C in presence of 1.5 μl of DMSO only or 1.5 μl of 1M7 (1-methyl-7-nitroisatoic anhydride) diluted in DMSO (final concentrations tested: 1, 2 and 4 mM). Modified RNAs were extracted by phenol/ chloroform and precipitated with Na-acetate and ethanol, in presence of 10 μg yeast RNA as carrier. After centrifugation, precipitates were dissolved in 4 μl of water, and reverse transcribed using radiolabeled primer ced267 (Supplementary Table S2) and Superscript IV reverse transcriptase (see Toeprint assays).
RESULTS
A point mutation in the +42 tisB mRNA 5′ stem-loop impairs 30S initiation complex formation and ribosome or S1 binding
In a previous study, we addressed the molecular mechanisms of, and structural elements required for, standby-mediated translation of the translationally active +42 tisB mRNA (14). We showed that r-protein S1 promotes 30S ribosomal subunit binding to the single-stranded standby site of the mRNA. In addition, we identified a 5′ structural element that is essential for binding of the 30S subunit, and of purified S1 protein alone, to the standby site in the mRNA (14). Deletion of this element abolished standby. Furthermore, introduction of a stem breaker mutation (CC to AA substitutions at pos. 50 & 51) in the 5′ end stem-loop (pos. 50 to 64; Figure 1C) of +42 tisB mRNA drastically impaired ribosome binding and formation of the 30S-IC (14). Building on these results and the known binding preferences of S1 for RNA pseudoknots, we speculated that the 5′ terminal stem-loop could be part of an RNA pseudoknot. If this were the case, its loop sequence should base-pair to accessible flanking sequences, most likely nearby, and loop mutations would be expected to give phenotypes similar to a stem-breaker mutation (14). To assess this possibility, we used the HotKnots software (44–47) to predict candidate RNA pseudoknot structures in a 50 nt window upstream of the IstR1 base-pairing site in the 5′ end region of +42 tisB mRNA. Of 19 predicted structures (of ΔG < –6 kcal/mol), 13 were pseudoknots (Supplementary Table S3). Interestingly, the most stable pseudoknot predicted (ΔG = –9.53 kcal/mol; S1 = 9 nt, S2 = 5 nt, L1 = 0 nt, L2 = 2 nt, L3 = 3 nt), suggests single-stranded nucleotides 73–77 to be base-paired to loop nucleotides 53–57 to form the S2 stem (Figure 1C and D). In this model, substitutions G to A at position 54 (G54A), C to A at position 55 (C55A), and G to C at position 57 (G57C) should prevent formation of the pseudoknot and thus translation of +42 tisB mRNA (Figure 1E). These three independent mutations were introduced into +42 tisB mRNA, and 30S-IC formation tested by toeprint assays in comparison to wild-type +42 tisB mRNA as control. As expected, a strong toeprint signal at position +15 relative to the AUG start codon was observed with the wild type +42 tisB mRNA when incubated with both 30S subunits and initiator tRNA (Figure 2A) (11,14). In contrast, all three loop mutants showed impaired 30S-IC formation. While weaker toeprint signals were observed with the G54A and C55A mutants (8- and 1.5-fold decrease, respectively), the signal for the G57C mutant mRNA was virtually absent (Figure 2A). This suggested that the loop nucleotides in the 5′ stem-loop may be involved in a higher order RNA structure whose formation is essential for standby-mediated translation of +42 tisB mRNA.
We previously reported that mutations or truncations in the 5′end of the +42 tisB mRNA that abolished translation were correlated with decreased affinity of mutant mRNAs for the 30S subunit as well as S1 alone (14). We therefore tested +42 mRNA carrying the mutation with the strongest effect on toeprinting, G57C, for binding by using fluorescence anisotropy (FA) measurements. This method uses polarized light to excite a fluorophore, FAM, attached to the 5′ end of the +42 tisB mRNA, and records emitted light in planes both parallel and perpendicular to the plane of excitation. The read-out — change in anisotropy—informs on rotational diffusion, which in turn depends on whether a ligand (here: S1 or the 30S subunit) is bound. This method is explained in detail in Supplementary Figure S3A, and has previously allowed us to monitor 30S binding to the tisB mRNA standby site in absence of initiator tRNA (11,14). FA measures interaction of RNA-protein complexes in solution and does not require fractionation of complexes and free RNAs as in EMSA or filter binding assays.
Changes in fluorescence anisotropy were measured using a 5′-end FAM-labeled mRNA incubated with 30S subunits (14). This complex was then challenged with either a 50-fold molar excess of unlabeled competitor wild-type +42 tisB mRNA or the G57C mutant mRNA (see Supplementary Figure S3B). Control experiments in absence of competitor gave a high change in fluorescence anisotropy, i.e. the signature of 30S binding to the standby-competent and translationally active 5′end-FAM labeled +42 mRNA (Figure 2B). Addition of unlabeled +42 tisB mRNA strongly reduced the fluorescence anisotropy change, demonstrating that the 30S subunit relocated from the labeled to the unlabeled +42 mRNA in excess (Figure 2B). In contrast, high changes in fluorescence anisotropy were still obtained when the 30S/5′FAM +42 mRNA complex was challenged with the G57C mutant mRNA (Figure 2B). This shows that the single loop base substitution impaired the mRNA’s affinity for the 30S ribosome, in line with its effect on toeprinting (Figure 2A). Since S1 is required for standby translation on tisB mRNA, the same experimental design was used with purified S1 protein alone. As for 30S, unlabeled wild-type +42 mRNA effectively competed S1 binding to the 5′-end FAM-labeled mRNA, whereas the G57C mutant mRNA was ineffective (Figure 2B).
Taken together, the toeprint and binding assay results indicate that the loop nucleotides in the 5′-end hairpin of the +42 mRNA are required for standby, consistent with a requirement for a complex RNA element, such as a pseudoknot.
The RNA pseudoknot structure constrains flexibility of the 5′UTR in the +42 tisB mRNA
Disruption of the putative pseudoknot by the most severe G57C substitution should be detectable by structure mapping. We therefore used SHAPE (selective 2′-hydroxyl acylation analyzed by primer extension) (48) to probe the differences between the 5′-UTR regions of wild-type and G57C mRNAs in vitro (Materials and Methods). Additional details of the method, and the experimental data obtained, are shown in Supplementary Figure S4A-C. The SHAPE results indeed support lower flexibility in the sequences encompassing the putative pseudoknot of wild-type +42 mRNA than of the G57C variant, in line with a disruption of local structure by the mutation. By contrast, SHAPE reactivities were unchanged in the standby region downstream (pos. 93 to 116), which is known to be single-stranded based on earlier chemical and enzymatic probing (11,14) (Supplementary Figure S4). Thus, structure probing combined with in silico prediction tentatively strengthens the pseudoknot prediction in Figure 1D.
Overexpression of an mRNA with a G57C substitution is non-toxic in vivo
TisB depolarizes the inner membrane and, when overexpressed, triggers growth arrest and cell death (4,7). We used plasmids expressing +42 tisB mRNA under the control of an arabinose-inducible promoter, and created a variant carrying the G57C base substitution. Cells harboring the empty vector control (ct), and plasmids expressing either wild-type or G57C mutant mRNA, were grown to mid-exponential growth phase, followed by addition of either glucose (control, uninduced plasmids) or arabinose (toxin mRNA induction). No noticeable growth defect was observed in the presence of glucose (Figure 3A), as expected in the absence of induced mRNA transcription (confirmed by Northern blot analysis, Supplementary Figure S5A). In contrast, arabinose induction of wild-type mRNAs resulted in immediate growth arrest in the case of +42 tisB mRNA, whereas the G57C mutant +42 mRNA was non-toxic and without any observable growth effect, although it was expressed at similar levels as wild-type +42 mRNA (Figure 3B, Supplementary Figure S5A).
We next evaluated the effect of wild-type and mutant mRNAs on cell viability by spotting serial dilutions of bacterial cultures 30 min post-induction on LA-Amp plates. Here, we additionally included constructs that generated +1 mRNAs; wild-type +1 mRNA is delayed-toxic since processing is required to generated the active +42 mRNA (4,7). As in the growth curve analysis (Figure 3A), glucose caused no growth effects (Figure 3C). Spotting assays carried out after arabinose induction indicated that +1 and +42 tisB mRNA expression drastically affected cell viability by 100 and 10 000-fold, respectively (Figure 3C), whereas viability remained unaffected when plasmids encoded +1 G57C or +42 G57C mRNAs. Thus, growth curves and cell viability assays recapitulate the known toxic effects of the wild-type mRNAs (+1 and +42). However, induction of the G57C mutant mRNA gave no toxicity/lethality even when overexpressed from a high-copy number plasmid. We can conclude that the G57C mutation abolishes S1/30S binding, translation initiation complex formation and toxicity in vivo.
A compensatory mutation in conjunction with G57C restores 30S initiation complex formation, 30S/ S1 binding, and in vivo toxicity
Point mutations in the 5′ end stem-loop, either in the stem or in the apical loop region, severely impaired tisB mRNA translation both in vitro and in vivo (Figures 2 and 3; (14)). Based on the pseudoknot prediction model in Figure 1D, a C to G substitution at position 74 should restore the five base-pair helix if combined with the G57C mutation in stem 2 of the pseudoknot (Figures 1C, D and 4A; for clarity, the left arm of the stem is boxed in grey, and the right arm in black, throughout the paper). Therefore, we designed two additional tisB mRNA mutants, C74G and the double (compensatory) G57C/C74G (Comp. 1, Figure 4A), and tested performance by toeprinting. For comparison, we used wild-type +42 tisB mRNA (positive control) and the G57C mutant mRNA (negative control). Again, the G57C mutant mRNA gave a barely detectable toeprint signal (≈20 fold lower compared to wild-type mRNA) (Figure 4B). The point mutation C74G alone, predicted to weaken or abolish pseudoknot formation, gave a detectable toeprint signal (1.8-fold reduction compared to wild-type mRNA) (see Discussion), and the double mutation G57C/C74G significantly improved 30S-IC formation over the single G57C, yet without reaching wild-type levels (4-fold lower than +42 mRNA; Figure 4B). These results suggest that the disruption of the proposed pseudoknot in the G57C mutant mRNA can be rescued by introducing a compensatory mutation matching the pseudoknot structure prediction.
To validate this result, competition assays with 5-′end FAM-labeled +42 mRNA were done as in Figure 2. Again, wild-type unlabeled +42 mRNA efficiently competed both 30S and protein S1 binding, whereas the G57C mutant mRNA failed to do so (Figure 4C and Supplementary Figure S6). Congruent with the toeprint results, combining the compensatory C74G mutation with G57C restored an efficient competitor capable of challenging both 30S subunit and S1 binding to the labeled mRNA (Figure 4C). Surprisingly, the C74G mutant alone was also an efficient competitor, in line with the toeprint assay (Figure 4B). These in vitro results indicate that the defects in ribosome binding and translation of the G57C mutant mRNA can be rescued by the compensatory base substitution C74G.
To address whether the G57C/C74G double mutant confers toxicity to the tisB mRNA in vivo, assays were carried out as before (Figure 3), with the C74G substitution introduced into either the wild-type +42 or the +42 G57C mutant mRNA. Expression of the mRNAs was induced at OD600 = 0.5 with either glucose (negative control) or arabinose, followed by growth measurements and spotting assays. As in Figure 3, the empty vector control failed to cause toxicity in presence of arabinose as did the G57C mutant (Figure 5A), even though tisB mRNA was expressed from the plasmid (Supplementary Figure S5B). Again, expression of wild-type +42 tisB mRNA stopped growth (Figure 5B). Interestingly, induction of the G57C/C74G double mutant (Comp. 1) mRNA gave similar lethality as wild-type +42 mRNA, both in liquid and on solid media (Figure 5B, C). Expression of the C74G single mutant mRNA arrested growth to a degree comparable to its wild-type counterpart in liquid medium (Figure 5B). However, spotting assays indicated 10-fold less toxicity compared to the wild-type +42 or the double mutant G57C/C74G (Figure 5C). Northern blot analysis confirmed that all mRNAs were expressed solely upon arabinose induction (Supplementary Figure S5B).
The effects of double nucleotide mutations strongly support the RNA pseudoknot predicted in the 5′UTR of +42 tisB mRNA
Even though the compensatory mutation G57C/C74G rescued the lack of toxicity observed with G57C alone, the C74G single mutant unexpectedly remained toxic (Figure 5B and C), and thus raised possible alternative explanations. To rigorously test the pseudoknot model, we therefore created three additional sets of mutations, each of which changes two nucleotides each in either the left or right arm of stem 2, or were combined to restore base-pairing. These mutations are shown on the pseudoknot structure in Figure 6A. First, a second base substitution, U56C, was combined with the G57C mutation to further destabilize stem 2 (U56C/G57C), and additional left arm mutants were G54C/C55G and G54C/G57C (Figure 6A). G54C/C55G was chosen because mutations in these two positions individually already impacted toeprinting signals (see Figure 2). The second set of two nt-change mutants were the corresponding (right arm) complements C74G/A75G, G76C/C77G and C74G/C77G. Finally, Comp 2, 3, and 4 were the quadruple mutations designed to restore stem 2 base-pairing in the three cases (Figure 6A).
Toxicity assays were performed as in Figure 5 with plasmid constructs expressing the panel of all these mutant +42 tisB mRNAs. TisB-mediated toxicity was monitored again in liquid culture and on solid media (Figure 6B-G). No noticeable growth defect was observed in the presence of glucose (Figure 6B, D, F). Disruption of the left side of stem 2: U56C/G57C (Figure 6B and C), G54C/C55G (Figure 6D and E), G54C/G57C (Figure 6F and G) abolished TisB-mediated toxicity both in liquid and on solid medium. Similarly, and unlike the effect of the C74G single mutant (Figure 5B and C), all double base substitutions on the right side of stem 2, C74G/A75G (Figure 6B and C), G76C/C77G (Figure 6D and E) and C74G/C77G (Figure 6F and G), were non-toxic. Strikingly, all compensatory mutations combining changes on both sides of stem 2 gave toxicity levels similar to that of the wild-type +42 tisB mRNA (Comp. 2–4; Figure 6B–G). Taken together, these results lend strong support for the presence of the RNA pseudoknot structure at the 5′end of the +42 tisB mRNA and its essentiality for translation of the toxin.
DISCUSSION
In this paper, we present in vitro and in vivo evidence that the apical loop residues of the 5′ terminal hairpin of the +42 tisB mRNA are involved in the formation of a pseudoknot structure which is essential for the functionality of the mRNA. First, we showed that three individual base substitutions in the apical loop impaired formation of the 30S-IC compared to wild-type +42 mRNA (Figure 2A). One of these, G57C, virtually abolished toeprint formation (Figures 2A and 4B). Fluorescence anisotropy experiments showed that this mutant mRNA had a decreased affinity for both 30S and S1 binding (Figure 2B), tentatively explaining the observed effects on 30S-IC formation. Plasmids overexpressing the tisB mRNA carrying the G57C mutation conferred a complete absence of toxic effects (Figure 3). We then created a point mutation, C74G, that compensated 30S-IC formation, 30S/S1 binding, and toxicity to the +42 G57C tisB mRNA (Figures 4 and 5). These mutations, G57C and C74G, matched the prediction of a stable pseudoknot (ΔG = –9.53 kcal/mol), obtained with HotKnots and PseudoViewer software (Figures 1D, 4A, Supplementary Table S3). Moreover, six double base substitutions disrupting either side of stem 2 (U56C/G57C, G54C/C55G, G54/G57, C74G/A75G, G76C/C77G, C74G/C77G) resulted in a complete loss of toxicity, whereas all three compensatory mutants (Comp. 2, 3, and 4)—designed to restore the pseudoknot structure (Figure 6A)—conferred toxicity identical (Comp 2 and 3; Figure 6B–E), or similar (Figure 6F and G), to wild-type +42 mRNA. The pseudoknot model that best matches both predicted and empirical data is of type H (S1 = 9 nt, S2 = 5 nt, L1 = 0 nt, L2 = 2 nt and L3 = 3 nt) (Figure 1D).
Could pseudoknots be a more general feature of toxin mRNAs? Several type I TA toxin loci in E. coli are non-homologous but share strikingly similar regulatory features (49). Like in the case of tisB, the zor toxin gene from the TA system zor-orz, and shoB from shoB-ohsC, are first transcribed into stably structured and translationally inactive mRNAs (50,51). Like for +42 tisB mRNA, nucleolytic cleavages generate 5′-truncated, translationally active mRNAs, denoted ‘+28’ for zor and ‘+40’ for shoB (51,52). Finally, like IstR1, the antitoxin RNAs Orz and OhsC inhibit translation of their cognate toxin mRNAs by base-pairing far upstream of the toxin RBS, suggesting a standby-dependent model of translational regulation (49,52,53). Based on these similarities, and strengthened by the observation that 5′-structures are required for standby activity for tisB (14), we hypothesize that pseudoknot RNA structures may play the role suggested by the present results also in these other toxin mRNAs. Indeed, HotKnots software run on tisB mRNA, and the two toxin mRNAs zor and shoB, within a 50 nt window preceding the annotated base-pairing site of the antitoxin sRNAs, suggested converging features (10,45,52,53). As for tisB, pseudoknots dominate the predicted structures for both zor (nine pseudoknots out of 16 predictions) and shoB (two out of two structure predictions) (10,52,53). The data obtained suggest structural diversity in the predicted pseudoknot topologies, both in stems and connected loop lengths (see Figure 7 for the most stable examples, and Supplementary Table S3 for a complete list). We propose that all these active mRNAs may carry pseudoknot motifs at equivalent positions. Differences in pseudoknot topology are not surprising when considering the diversity of known S1-binding pseudoknots in general (Supplementary Figure S1) (26,36,37,40). Hence, it is tempting to speculate that the enterobacterial type I TA systems that rely on standby-dependent toxin translation share key features. Standby in tisB strictly requires S1 for proper anchoring of the 30S ribosome to the standby site and unwinding activity towards the toxin RBS, and this in turn is dependent on a 5′ structure element (14). We argue here that this structure conforms to a pseudoknot topology that creates high affinity for S1 binding, which might well play an equivalent role in the two other toxin mRNAs as detailed above.
It is worth mentioning that the definition of standby has become more complicated since the original model was proposed (13,54). For instance, the relationship between a translational enhancer and a standby site is not entirely clear, and may well be overlapping. Enhancers are often found in close vicinity of bacterial mRNAs’ RBSs and often stimulate translation by recruiting S1 (21,24,55). Standby sites can also act as translation enhancers. For instance, one study convincingly demonstrated that a standby region immediately upstream of an accessible, not structurally sequestered RBS in the lpp mRNA can kinetically boost the translation rate. In this case, this occurs because a standby-bound 30S is already present immediately upstream of the 70S ribosome residing at the RBS. Thereby, standby binding enables rapid re-initiation once the leading 70S enters elongation and departs from the RBS (56). Clearly, different translation-enhancing effects caused by standby or ‘enhancers’ may share common denominators, such as a prominent role of ribosomal protein S1 (21,24,55,57,58). However, cases like that of tisB mRNA are distinct in that they require standby to overcome RNA structure at a great distance, and where translation—in line with the original standby model—without standby is at background level (10–13,54). We argue here that, particularly in the cases where standby occurs far upstream of stably structured RBSs, a significantly long 30S residence time on the standby site is required. Based on our results, and suggested by comparisons to other TA toxin mRNAs that share the same regulatory pattern, we propose that 5′-pseudoknots together with nearby unstructured regions make up the two elements that together create the high affinity binding sites for S1 and/or 30S required for a significantly long dwelling time. This in turn would permit S1 to act as an ‘unwindase’ to promote progression of the 30S through the impeding structure—which is unique to systems in which standby occurs at a great distance—to ultimately access the toxin RBS. Clearly, it will be of great interest to obtain high-resolution structures of 5′-segments of tisB mRNA in order to substantiate the proposed model.
Supplementary Material
ACKNOWLEDGEMENTS
Initiator tRNA was a generous gift from S. Sanyal. We are grateful to S. Deindl for help with fluorescence anisotropy experiments. We acknowledge A.-C. Le Foll and P. Romby for SHAPE probing protocols, and thank E. Westhof for invaluable advice on RNA pseudoknots. A. Lippegaus acknowledges support from the ERASMUS program.
Notes
Present address: Anne Lippegaus, Institute of Microbiology, Friedrich-Schiller-University Jena, 07745 Jena, Germany.
Contributor Information
Cédric Romilly, Department of Cell and Molecular Biology, Uppsala University, Uppsala S-75124, Sweden.
Anne Lippegaus, Department of Cell and Molecular Biology, Uppsala University, Uppsala S-75124, Sweden.
E Gerhart H Wagner, Department of Cell and Molecular Biology, Uppsala University, Uppsala S-75124, Sweden.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
FUNDING
Swedish Research Council (to E.G.H.W.). Funding for open access charge: Swedish Research Council.
Conflict of interest statement. None declared.
REFERENCES
- 1. Lewis L.K., Harlow G.R., Gregg-Jolly L.A., Mount D.W.. Identification of high affinity binding sites for LexA which define new DNA damage-inducible genes in Escherichia coli. J. Mol. Biol. 1994; 241:507–523. [DOI] [PubMed] [Google Scholar]
- 2. Courcelle J., Khodursky A., Peter B., Brown P.O., Hanawalt P.C.. Comparative gene expression profiles following UV exposure in wild-type and SOS-deficient Escherichia coli. Genetics. 2001; 158:41–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Fernández De Henestrosa A.R., Ogi T., Aoyagi S., Chafin D., Hayes J.J., Ohmori H., Woodgate R.. Identification of additional genes belonging to the LexA regulon in Escherichia coli. Mol. Microbiol. 2000; 35:1560–1572. [DOI] [PubMed] [Google Scholar]
- 4. Unoson C., Wagner E.G.H.. A small SOS-induced toxin is targeted against the inner membrane in Escherichia coli. Mol. Microbiol. 2008; 70:258–270. [DOI] [PubMed] [Google Scholar]
- 5. Dörr T., Vulić M., Lewis K.. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol. 2010; 8:e1000317. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Berghoff B.A., Karlsson T., Källman T., Wagner E.G.H., Grabherr M.G.. RNA-sequence data normalization through in silico prediction of reference genes: the bacterial response to DNA damage as case study. BioData Min. 2017; 10:30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Berghoff B.A., Hoekzema M., Aulbach L., Wagner E.G.H.. Two regulatory RNA elements affect TisB-dependent depolarization and persister formation. Mol. Microbiol. 2017; 103:1020–1033. [DOI] [PubMed] [Google Scholar]
- 8. Stapels D.A.C., Hill P.W.S., Westermann A.J., Fisher R.A., Thurston T.L., Saliba A.-E., Blommestein I., Vogel J., Helaine S.. Salmonella persisters undermine host immune defenses during antibiotic treatment. Science. 2018; 362:1156–1160. [DOI] [PubMed] [Google Scholar]
- 9. Gollan B., Grabe G., Michaux C., Helaine S.. Bacterial persisters and infection: Past, present, and progressing. Annu. Rev. Microbiol. 2019; 73:359–385. [DOI] [PubMed] [Google Scholar]
- 10. Vogel J., Argaman L., Wagner E.G.H., Altuvia S.. The small RNA IstR inhibits synthesis of an SOS-induced toxic peptide. Curr. Biol. 2004; 14:2271–2276. [DOI] [PubMed] [Google Scholar]
- 11. Darfeuille F., Unoson C., Vogel J., Wagner E.G.H.. An antisense RNA inhibits translation by competing with standby ribosomes. Mol. Cell. 2007; 26:381–392. [DOI] [PubMed] [Google Scholar]
- 12. Sterk M., Romilly C., Wagner E.G.H.. Unstructured 5′-tails act through ribosome standby to override inhibitory structure at ribosome binding sites. Nucleic Acids Res. 2018; 46:4188–4199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. de Smit M.H., van Duin J.. Translational standby sites: how ribosomes may deal with the rapid folding kinetics of mRNA. J. Mol. Biol. 2003; 331:737–743. [DOI] [PubMed] [Google Scholar]
- 14. Romilly C., Deindl S., Wagner E.G.H.. The ribosomal protein S1-dependent standby site in tisB mRNA consists of a single-stranded region and a 5′ structure element. Proc. Natl. Acad. Sci. U.S.A. 2019; 116:15901–15906. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Qu X., Lancaster L., Noller H.F., Bustamante C., Tinoco I.. Ribosomal protein S1 unwinds double-stranded RNA in multiple steps. Proc. Natl. Acad. Sci. U.S.A. 2012; 109:14458–14463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Rajkowitsch L., Schroeder R.. Dissecting RNA chaperone activity. RNA. 2007; 13:2053–2060. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Sørensen M.A., Fricke J., Pedersen S.. Ribosomal protein S1 is required for translation of most, if not all, natural mRNAs in Escherichia coli in vivo. J. Mol. Biol. 1998; 280:561–569. [DOI] [PubMed] [Google Scholar]
- 18. Subramanian A.-R., van Duin J.. Exchange of individual ribosomal proteins between ribosomes as studied by heavy isotope-transfer experiments. Molec. Gen. Genet. 1977; 158:1–9. [DOI] [PubMed] [Google Scholar]
- 19. Suryanarayana T., Subramanian A.R.. An essential function of ribosomal protein S1 in messenger ribonucleic acid translation. Biochemistry. 1983; 22:2715–2719. [DOI] [PubMed] [Google Scholar]
- 20. Hajnsdorf E., Boni I.V.. Multiple activities of RNA-binding proteins S1 and Hfq. Biochimie. 2012; 94:1544–1553. [DOI] [PubMed] [Google Scholar]
- 21. Komarova A.V., Tchufistova L.S., Dreyfus M., Boni I.V.. AU-Rich sequences within 5′ untranslated leaders enhance translation and stabilize mRNA in Escherichia coli. J. Bacteriol. 2005; 187:1344–1349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Cifuentes-Goches J.C., Hernández-Ancheyta L., Guarneros G., Oviedo N., Hernández-Sánchez J.. Domains two and three of Escherichia coli ribosomal S1 protein confers 30S subunits a high affinity for downstream A/U-rich mRNAs. J. Biochem. 2019; 166:29–40. [DOI] [PubMed] [Google Scholar]
- 23. Hook-Barnard I.G., Brickman T.J., McIntosh M.A.. Identification of an AU-rich translational enhancer within the Escherichia coli fepB leader RNA. J. Bacteriol. 2007; 189:4028–4037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Azam M.S., Vanderpool C.K.. Translation inhibition from a distance: The small RNA SgrS silences a ribosomal protein S1-dependent enhancer. Mol. Microbiol. 2020; 114:391–408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Boni I.V., Artamonova V.S., Tzareva N.V., Dreyfus M.. Non‐canonical mechanism for translational control in bacteria: synthesis of ribosomal protein S1. EMBO J. 2001; 20:4222–4232. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Duval M., Korepanov A., Fuchsbauer O., Fechter P., Haller A., Fabbretti A., Choulier L., Micura R., Klaholz B.P., Romby P. et al.. Escherichia coli ribosomal protein S1 unfolds structured mRNAs onto the ribosome for active translation Initiation. PLoS Biol. 2013; 11:e1001731. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Kolb A., Hermoso J.M., Thomas J.O., Szer W.. Nucleic acid helix-unwinding properties of ribosomal protein S1 and the role of S1 in mRNA binding to ribosomes. Proc. Natl. Acad. Sci. U.S.A. 1977; 74:2379–2383. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Qureshi N.S., Bains J.K., Sreeramulu S., Schwalbe H., Fürtig B.. Conformational switch in the ribosomal protein S1 guides unfolding of structured RNAs for translation initiation. Nucleic Acids Res. 2018; 46:10917–10929. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Sacerdot C., Caillet J., Graffe M., Eyermann F., Ehresmann B., Ehresmann C., Springer M., Romby P.. The Escherichia coli threonyl-tRNA synthetase gene contains a split ribosomal binding site interrupted by a hairpin structure that is essential for autoregulation. Mol. Microbiol. 1998; 29:1077–1090. [DOI] [PubMed] [Google Scholar]
- 30. Hilbers C.W., Michiels P.J.A., Heus H.A.. New developments in structure determination of pseudoknots. Biopolymers. 1998; 48:137–153. [DOI] [PubMed] [Google Scholar]
- 31. Peselis A., Serganov A.. Structure and function of pseudoknots involved in gene expression control. Wiley Interdiscip. Rev. RNA. 2014; 5:803–822. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Westhof E., Jaeger L.. RNA pseudoknots. Curr. Opin. Struct. Biol. 1992; 2:327–333. [Google Scholar]
- 33. van Batenburg F.H.D., Gultyaev A.P., Pleij C.W.A.. PseudoBase: structural information on RNA pseudoknots. Nucleic Acids Res. 2001; 29:194–195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Gultyaev A.P., Olsthoorn R.C., Pleij C.W., Westhof E.. RNA structure: pseudoknots. eLS. 2012; doi:10.1002/9780470015902.a0003134.pub2. [Google Scholar]
- 35. Han K., Byun Y.. PseudoViewer2: visualization of RNA pseudoknots of any type. Nucleic Acids Res. 2003; 31:3432–3440. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Ringquist S., Jones T., Snyder E.E., Gibson T., Boni I., Gold L.. High-affinity RNA ligands to Escherichia coli ribosomes and ribosomal protein S1: Comparison of natural and unnatural binding sites. Biochemistry. 1995; 34:3640–3648. [DOI] [PubMed] [Google Scholar]
- 37. Bordeau V., Felden B.. Ribosomal protein S1 induces a conformational change of tmRNA; more than one protein S1 per molecule of tmRNA. Biochimie. 2002; 84:723–729. [DOI] [PubMed] [Google Scholar]
- 38. Wower I.K., Zwieb C.W., Guven S.A., Wower J.. Binding and cross-linking of tmRNA to ribosomal protein S1, on and off the Escherichia coli ribosome. EMBO J. 2000; 19:6612–6621. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Wower I.K., Zwieb C., Wower J.. Contributions of pseudoknots and protein SmpB to the structure and function of tmRNA in trans-translation. J. Biol. Chem. 2004; 279:54202–54209. [DOI] [PubMed] [Google Scholar]
- 40. Lund P.E., Chatterjee S., Daher M., Walter N.G.. Protein unties the pseudoknot: S1-mediated unfolding of RNA higher order structure. Nucleic Acids Res. 2020; 48:2107–2125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Hoekzema M., Romilly C., Holmqvist E., Wagner E.G.H.. Hfq‐dependent mRNA unfolding promotes sRNA‐based inhibition of translation. EMBO J. 2019; 38:e101199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Moore M.J., Sharp P.A.. Site-specific modification of pre-mRNA: the 2′-hydroxyl groups at the splice sites. Science. 1992; 256:992–997. [DOI] [PubMed] [Google Scholar]
- 43. Akiyama B.M., Stone M.D.. Chapter 2 - Assembly of complex RNAs by splinted ligation. Methods in Enzymology, Biophysical, Chemical, and Functional Probes of RNA Structure, Interactions and Folding: Part B. 2009; 469:Academic Press; 27–46. [DOI] [PubMed] [Google Scholar]
- 44. Ren J., Rastegari B., Condon A., Hoos H.H.. HotKnots: Heuristic prediction of RNA secondary structures including pseudoknots. RNA. 2005; 11:1494–1504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Andronescu M.S., Pop C., Condon A.E.. Improved free energy parameters for RNA pseudoknotted secondary structure prediction. RNA. 2010; 16:26–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Han K., Lee Y., Kim W.. PseudoViewer: automatic visualization of RNA pseudoknots. Bioinformatics. 2002; 18:S321–S328. [DOI] [PubMed] [Google Scholar]
- 47. Byun Y., Han K.. PseudoViewer3: generating planar drawings of large-scale RNA structures with pseudoknots. Bioinformatics. 2009; 25:1435–1437. [DOI] [PubMed] [Google Scholar]
- 48. Smola M.J., Rice G.M., Busan S., Siegfried N.A., Weeks K.M.. Selective 2′-hydroxyl acylation analyzed by primer extension and mutational profiling (SHAPE-MaP) for direct, versatile, and accurate RNA structure analysis. Nat. Protoc. 2015; 10:1643–1669. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Fozo E.M. New type I toxin-antitoxin families from ‘wild’ and laboratory strains of E. coli: Ibs-Sib, ShoB-OhsC and Zor-Orz. RNA Biol. 2012; 9:1504–1512. [DOI] [PubMed] [Google Scholar]
- 50. Kawano M., Reynolds A.A., Miranda-Rios J., Storz G.. Detection of 5′- and 3′-UTR-derived small RNAs and cis-encoded antisense RNAs in Escherichia coli. Nucleic Acids Res. 2005; 33:1040–1050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Wen J., Harp J.R., Fozo E.M.. The 5′ UTR of the type I toxin ZorO can both inhibit and enhance translation. Nucleic Acids Res. 2017; 45:4006–4020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Fozo E.M., Kawano M., Fontaine F., Kaya Y., Mendieta K.S., Jones K.L., Ocampo A., Rudd K.E., Storz G.. Repression of small toxic protein synthesis by the Sib and OhsC small RNAs. Mol. Microbiol. 2008; 70:1076–1093. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Wen J., Won D., Fozo E.M.. The ZorO-OrzO type I toxin–antitoxin locus: repression by the OrzO antitoxin. Nucleic Acids Res. 2014; 42:1930–1946. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. de Smit M.H., van Duin J.. Secondary structure of the ribosome binding site determines translational efficiency: a quantitative analysis. Proc. Natl. Acad. Sci. U.S.A. 1990; 87:7668–7672. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Aseev L.V., Koledinskaya L.S., Boni I.V.. Autogenous regulation in vivo of the rpmE gene encoding ribosomal protein L31 (bL31), a key component of the protein–protein intersubunit bridge B1b. RNA. 2020; 26:814–826. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Andreeva I., Belardinelli R., Rodnina M.V.. Translation initiation in bacterial polysomes through ribosome loading on a standby site on a highly translated mRNA. Proc. Natl. Acad. Sci. U.S.A. 2018; 115:4411–4416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Komarova A.V., Tchufistova L.S., Supina E.V., Boni I.V.. Protein S1 counteracts the inhibitory effect of the extended Shine-Dalgarno sequence on translation. RNA. 2002; 8:1137–1147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Takahashi S., Furusawa H., Ueda T., Okahata Y.. Translation enhancer improves the ribosome liberation from translation initiation. J. Am. Chem. Soc. 2013; 135:13096–13106. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.